Equities

EZZ Life Science Holdings Ltd

EZZ:ASX

EZZ Life Science Holdings Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)1.07
  • Today's Change0.085 / 8.67%
  • Shares traded137.91k
  • 1 Year change+85.22%
  • Beta--
Data delayed at least 20 minutes, as of May 31 2024 07:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

EZZ Life Science Holdings Limited is an Australia-based genomic life science company. The Company is engaged in research and development in genomics and precision nutrition with a focus on four human health challenges, including genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. It formulates, produces, markets and distributes health supplements under the brand of EZZ to retailers and consumers domestically and internationally. The Company is also a wholesale distributor of skin care products under the EAORON brand in Australia and New Zealand to pharmacies, supermarkets and specialist retailers. Its products under the EZZ brand include EZZ Hair Growth Spray, EZZ Hair Scrub, EZZ Hair Mask, EZZ Anti-frizz Hair Spray, EZZ Biotic Engastro Capsule, EZZ Coffee Jelly and EZZ Iron Jelly. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, herbal/ traditional and pediatric consumer health products.

  • Revenue in AUD (TTM)43.71m
  • Net income in AUD3.47m
  • Incorporated2015
  • Employees--
  • Location
    EZZ Life Science Holdings Ltd104 Derby StreetSYDNEY 2128AustraliaAUS
  • Phone+61 28002-1376
  • Websitehttps://ezzlife.com.au/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Exceed World Inc34.50m-1.99m31.75m41.00--1.33--0.9202-0.0405-0.04050.7020.48730.895310.42424.59559,890.50-5.174.14-7.276.1750.1948.99-5.774.023.01-622.740.0019---25.27-5.76-113.33---31.13--
Liberta Co Ltd70.63m-67.30k34.05m118.00--2.4524.590.4821-2.34-2.342,487.28482.671.202.677.6562,643,520.00-0.10683.75-0.21696.4238.2441.81-0.08912.370.82473.150.694835.676.779.76-2.77-12.8523.12--
Medical Developments International Ltd33.49m-19.21m36.68m68.00--0.4846--1.10-0.2226-0.22260.38820.8770.33481.016.18---19.20-6.67-22.18-7.4369.6469.90-57.36-23.551.93--0.0311--47.3713.1254.79---6.41--
Delko SA344.52m6.40m38.16m1.16k5.970.64263.040.11081.401.4075.4813.012.650.168011.04--4.93--8.46--98.30--1.86--0.7361849.720.3958--------------
Penta Valent Tbk PT245.80m3.77m44.10m--11.561.9710.250.179423.3623.361,525.15137.393.068.956.37--4.69--15.53--12.01--1.54--0.925811.070.2678--15.71--53.62------
Rhone Ma Holdings Bhd65.83m3.89m46.62m--16.340.88938.350.70830.04040.04040.68420.74220.94242.934.98--6.266.157.477.3826.4028.116.646.852.9113.360.14432.112.418.46-5.163.72-27.03-7.79
EZZ Life Science Holdings Ltd43.71m3.47m47.30m--13.082.9712.491.080.08140.08141.020.35822.489.6313.51--19.6921.2224.8529.1974.7755.317.949.113.61293.270.019513.08147.26--176.57------
Microalliance Group Inc34.40m14.76m55.04m30.004.441.203.681.600.01350.01350.03250.05010.76310.486912.65762,790.3032.74--35.89--68.46--42.90--12.67--0.00--3,030.68--3,074.43------
COSMO BIO COMPANY, LIMITED90.34m3.90m58.13m155.0014.380.659310.710.643569.9469.941,620.671,525.810.84846.092.8761,000,000.003.805.624.546.7233.8237.404.486.235.15--0.002133.53-2.235.16-14.5111.20-8.0316.47
Rekah Pharmaceutical Industry Ltd130.30m-2.80m60.55m434.00--0.95936.500.4647-0.6267-0.626729.3713.520.68942.562.56---1.480.543-2.130.736424.9326.41-2.150.83671.080.29540.5414--10.0110.13-238.56---4.89--
Data as of May 31 2024. Currency figures normalised to EZZ Life Science Holdings Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.